- Home
- IVA vs BCV Comparison
IVA vs BCV Comparison
Compare IVA & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- BCV
- Stock Information
- Founded
- IVA 2011
- BCV 1971
- Country
- IVA France
- BCV United States
- Employees
- IVA N/A
- BCV N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- BCV Finance/Investors Services
- Sector
- IVA Health Care
- BCV Finance
- Exchange
- IVA Nasdaq
- BCV Nasdaq
- Market Cap
- IVA 117.3M
- BCV 105.5M
- IPO Year
- IVA 2020
- BCV N/A
- Fundamental
- Price
- IVA $2.51
- BCV $18.48
- Analyst Decision
- IVA Strong Buy
- BCV
- Analyst Count
- IVA 4
- BCV 0
- Target Price
- IVA $14.00
- BCV N/A
- AVG Volume (30 Days)
- IVA 28.6K
- BCV 26.3K
- Earning Date
- IVA 09-25-2024
- BCV 01-01-0001
- Dividend Yield
- IVA N/A
- BCV 8.13%
- EPS Growth
- IVA N/A
- BCV N/A
- EPS
- IVA N/A
- BCV N/A
- Revenue
- IVA $20,652,523.00
- BCV N/A
- Revenue This Year
- IVA N/A
- BCV N/A
- Revenue Next Year
- IVA $361.78
- BCV N/A
- P/E Ratio
- IVA N/A
- BCV N/A
- Revenue Growth
- IVA N/A
- BCV N/A
- 52 Week Low
- IVA $1.53
- BCV $14.09
- 52 Week High
- IVA $4.75
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- IVA 45.32
- BCV 77.33
- Support Level
- IVA $2.52
- BCV $17.65
- Resistance Level
- IVA $2.77
- BCV $18.41
- Average True Range (ATR)
- IVA 0.13
- BCV 0.26
- MACD
- IVA -0.03
- BCV 0.07
- Stochastic Oscillator
- IVA 0.00
- BCV 91.77
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.